CompletedNot Applicable

Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery

Nepal1,530 participantsStarted 2024-05-23

Plain-language summary

Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged \>18 years * Underwent major gastrointestinal or hepatobiliary surgery * Surgery performed under general anesthesia * Major surgery defined as any operative intervention in the abdominal or hepatobiliary region requiring general anesthesia Exclusion Criteria: * History of VTE within 3 months before surgery * Known hypercoagulable state or congenital thrombophilia * Diagnosis of atrial fibrillation * Undergoing systemic cancer chemotherapy or radiotherapy within the past 15 days * Pregnant or lactating women * Missing information in clinical records * Non-operated patients or those receiving conservative management * Patients undergoing liver transplantation

What they're measuring

Use of Thromboprophylaxis and Incidence of DVT in Major GI and Hepatobiliary Surgeries

Timeframe: From date of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first

Trial details

NCT IDNCT07088575

SponsorMaharajgunj Medical Campus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-21

View on ClinicalTrials.gov More Gastrointestinal trials